LumiRx is committed to supporting your company in achieving full DSCSA compliance.
How we can help!
Conduct thorough assessments to identify gaps in DSCSA compliance and provide tailored action plans.
Compliance Assessment
We offer expert consultation to guide clients through the waiver or exemption application process and ensure all regulatory requirements are met.
Advisory Services
Implement or upgrade systems for interoperable electronic data exchange to meet DSCSA standards.
Training Programs
We assist in preparing detailed justification and supporting documentation required for waiver or exemption requests.
Documentation Support
Get. Compliant. Now.
The Drug Supply Chain Security Act (DSCSA) compliance deadline is fast approaching on March 26, 2025. The FDA has confirmed that it will not extend the deadline any further. Ensuring compliance is critical to avoid operational disruptions and penalties.
Through our NFC technology integration and employee training, we help you achieve operational efficiency and compliance.
We will have your company DSCSA Compliant before the deadline.
Step 3:
We offer documentation support to ensure your waiver or exemption requests are thorough and well-organized.
Our expertise ensures all necessary information is accurately presented, significantly improving your chances of FDA approval.
Step 2:
Step 1:
Take our Assessment
Our compliance assessment identifies gaps in your current DSCSA practices, providing a clear action plan to address critical areas swiftly.
This focused approach saves time and resources, ensuring a higher likelihood of a successful waiver or exemption application.
DSCSA Compliance in 3 Simple Steps!
What Sets Us Apart
LumiRx's advanced tracking technology provides seamless solutions for product authentication and real-time data transfer. Our proprietary RXJ-33 chips, embedded directly into products, facilitate efficient tracking and verification at every stage of the supply chain.
RXJ-33 enables instantaneous data transfer, ensuring compliance officers always have the most current information available, enhancing operational efficiency and decision-making.
Ensure your medicines meet DSCSA compliance by embedding our RXJ-33 tags before March 26, 2024.
Our tags provide seamless traceability and verification, safeguarding your supply chain from disruptions. Without compliance, your products risk being returned or destroyed.
Act now to stay ahead and maintain the integrity of your products with our advanced technology.